New Strategies for Identifying and Developing Novel Vaccines: Genome-Based Discoveries

Fighting Infection in the 21st Century

Volumn , Issue , 2008, Pages 217-236

  Lissolo, Ling ^a   Quentin Millet, Marie José ^a  

^a SANOFI PASTEUR   (France)

Author keywords

Antigens; Diseases; Genome; Vaccination; Vaccines

Indexed keywords

EID: 84948757140     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470695951.ch13     Document Type: Chapter

References (59)

1. Ajjan, N. (1995). History. In Vaccination, pp. 6-7. Edited by Pasteur Mérieux MSD. Pasteur Mérieux MSD.
2. Alm, R. A., Ling, L.-S. L., Moir, D.T.& 20 other authors (1999). Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature 397, 176-180.
3. Austrian, R. (1989). Pneumococcal polysaccharide vaccines. Reviews of Infectious Diseases 3, S598-602.
4. Batchelder, M., Fox, J. G., Monath, T. & 8 other authors (1996). Oral vaccination with recombinant urease reduces gastric Helicobacter pylori colonization in the cat. Gastroenterology 110, A58.
5. Behr, M. A., Wilson, M.A., Gill, W. P., Salamon, H., Schollnick, G. K., Rane, S. & Small, P. M. (1999). Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284, 1520-1523.
6. Blanton, K. J., Biswas, G.D., Tsai, J., Adams, J., Dyer, D.W., Davis, S. M., Koch, G. G., Sen, P. K. & Sparling, P. F. (1990). Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin. Journal of Bacteriology 172, 5225-5235.
7. Boren, T., Falk, P., Roth, K. A., Larson, G.& Normark, S. (1993). Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262, 1892-1895.
8. Cadoz, M. (1998). Potential and limitations of polysaccharide vaccines in infancy. Vaccine 16, 1391-1395.
9. Chen, M., Lee, A. & Hazell, S. (1992). Immunization against gastric Helicobacter infection in a mouse Helicobacter felis model. Lancet 339, 1120-1121.
10. Cornelissen, C. N. & Sparling, P. F. (1994). Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. MolecularMicrobiology 14, 843-850.
11. Czinn, S. J. & Nedrud, J. G. (1991). Oral immunization against Helicobacter pylori. Infection and Immunity 59, 2359-2363.
12. Czinn, S. J., Cai, A. & Nedrud, J.C. (1993). Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 11, 637-642.
13. Eaton, K. A. & Krakowka, S. (1992). Chronic active gastritis due to Helicobacter pylori in immunized gnotobiotic piglets. Gastroenterology 103, 1580-1586.
14. Ferrero, R. L., Thiberge, J. M., Huerre, M.& Labigne, A. (1994). Recombinant antigens prepared from the urease subunits of Helicobacter spp: evidence of protection in a mouse model of gastric infection. Infection and Immunity 62, 4981-4989.
15. Ferrero, R. L., Thiberge, J. M., Huerre, M.& Labigne, A. (1995). The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proceedings of the National Academy of Sciences, USA 92, 6499-6503.
16. Fleischmann, R.D., Adams, M.D., White, O. & 37 other authors (1995). Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269, 496-512.
17. Fraser, M. & Fleischmann, R.D. (1997). Strategies for whole microbial genome sequencing and analysis. Electrophoresis 18, 1207-1216.
18. Gardner, M. J., Tettelin, H., Carucci, D. J. & 24 other authors (1998). Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. Science 282, 1126-1132.
19. Guy, B., Hessler, C., Fourage, S., Haensler, J., Vialon-Lafay, E., Rokbi, B. & Quentin-Millet, M. J. (1998). Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 16, 850-856.
20. Handfield, M. & Levesque, R. C. (1999). Strategies for isolation of in vivo expressed genes from bacteria. FEMS Microbiology Reviews 23, 69-91.
21. Hood, D.W., Deadman, M. E., Allen, T. & 7 other authors (1996). Use of the complete genome sequence information of Haemophilus influenzae strain Rd to investigate lipopolysaccharide biosynthesis. Molecular Microbiology 22, 951-965.
22. Horton, P.& Nakai, K. (1996). A probabilistic classification system for predicting the cellular localization sites of proteins. Intelligent Systems for Molecular Biology 4, 109-115.
23. Ilver, D., Arnqvist, A., Ogren, J. & 7 other authors (1998). Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279, 373-377.
24. Jones, D. A. & Fitzpatrick, F.A. (1999). Genomics and the discovery of new drug targets. Current Opinion in Chemical Biology 3, 71-76.
25. Kleanthous, H., Tibbits, T., Bahios, T. J., Georgokopoulos, K., Myers, G., Ermak, T. H., Fox, J.& Monath, T. (1995). in vivo selection of a highly adapted H. pylori isolate and the development of an H. pylori mouse model for studying vaccine efficacy. Gut 37, A94.
26. Labigne, A., Cussac, V. & Courcoux, P. (1991). Shuttle cloning and nucleotide sequence of Helicobacter pylori genes responsible for urease activity. Journal of Bacteriology 173, 1920-1931.
27. Lee, C. K., Weltzin, R., Thomas, W.D., Kleanthous, H., Ermak, T., Soman, G., Hill, J. E., Ackerman, S.& Monath, T. (1995). Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. Journal of Infectious Diseases 172, 161-172.
28. Lee, C. K., Soike, K. & Tibbits, T. (1996). Urease immunization protects against reinfection by Helicobacter pylori infection in rhesus monkeys. Gut 39, A43.
29. Lissolo, L., Fourrichon, L., Kleanthous, H., Guinet, F., Myers, G. & Quentin-Millet, M. J. (1998). Purification and preliminary characterization of a novel membrane protein from Helicobacter pylori and its use as a vaccine candidate. Abstracts of the 98th General Meeting of the American Society for Microbiology, Atlanta. Abstract B382. Washington D.C.American Society for Microbiology.
30. Marchall, A. & Hodgson, J. (1998). DNA chips: an array of possibilities. Nature Biotechnology 16, 27-31.
31. Marchetti, M., Arico, B., Burroni, D., Figure, N., Rappuoli, R. & Ghiara, P. (1995). Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 267, 1655-1658.
32. Marshall, B. J.& Warren, J.R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311-1315.
33. Mégraud, F. (1994). Helicobacter pylori resistance to antibiotics. In Helicobacter pylori: Basic Mechanisms to Clinical Cure, pp. 570-583. Edited by R. H.Hunt & G. N. J. Tytgat. Dordrecht: Kluwer Academic Publishers.
34. Michetti, P., Corthésy-Theulaz, I., Davin, C. & 7 other authors (1990). Immunization of BALB/c mice against H. felis infection with H. pylori urease. Gastroenterology 107, 1002-1011.
35. Moir, D. T., Shaw, K. J., Hare, R. S.& Vovis, G.F. (1999). Genomics and antimicrobial drug discovery. Antimicrobial Agents and Chemotherapy 43, 439-446.
36. Morse, S. I.& Morse, J. H. (1976). Isolation and properties of the leucocytosis-and lymphocytosis-promoting factor of Bordetella pertussis. Journal of Experimental Medicine 143, 1483-1502.
37. Moxon, E. R., Hood, D.& Richards, J. (1998). Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections. Advances in Experimental Medicine and Biology 435, 237-243.
38. Munoz, J. J., Arai, H. & Cole, R. L. (1981). Mouseprotecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infection and Immunity 32, 243-250.
39. Myers, L. E., Yang, Y. P., Du, R. P., Wang, Q., Harkness, R. E., Schryvers, A.B., Klein, M. H. & Loosmore, S.M. (1998). The transferrin binding protein B ofMoraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen. Infection and Immunity 66, 4183-4192.
40. National Institutes of Health (1994). Consensus development conference statement: Helicobacter pylori in peptic ulcer disease. JAMA (Journal of the American Medical Association) 272, 65-69.
41. Odenbreit, S., Till, M., Hofreuter, D. & Hass, R. (1999). Genetic and functional characterization of the AlpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue. Molecular Microbiology 31, 1537-1548.
42. Pallen, M. J.& Clayton, C. L. (1990). Vaccination against Helicobacter pylori urease. Lancet 336, 186-187.
43. Pittman, M. (1984). The concept of pertussis as a toxin-mediated disease. Pediatric Infectious Disease Journal 3, 467-486.
44. Pizza, M., Scarlato, V., Masignani, V.& 33 other authors (2000). Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816-1820.
45. Plotkin, S. L. & Plotkin, S.A. (1999). A short history of vaccination. In Vaccines, pp. 1-12. Edited by S. A. Plotkin & W. A. Orenstein. The Curtis Center, Philadelphia: W. B. Saunders.
46. Radcliff, F. J., Hazell, S. L., Kolesnikow, T., Doidge, C. & Lee, A. (1997). Catalase, a novel antigen for Helicobacter pylori vaccination. Infection and Immunity 65, 4668-4674.
47. Salk, J. & Salk, D. (1977). Control of influenza and poliomyelitis with killed virus vaccines. Science 195, 834-847.
48. Sanger, F., Air, G. M., Barrell, B. G., Brown, N. L., Coulson, A. R., Fiddes, C. A., Hutchison, C. A., Slocombe, P. M. & Smith, M. (1977). Nucleotide sequence of bacteriophage phi X174 DNA. Nature 265, 687-695.
49. Sanger, F., Nicklen, S. & Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of Sciences, USA 74, 5463-5467.
50. Schena, M., Heller, R. A., Theriault, T. P., Konrad, K., Lachenmeier, E. & Davis, R.W. (1998). Microarrays: biotechnology's discovery platform for functional genomics. Trends in Biotechnology 16, 301-306.
51. Schryvers, A.B.& Morris, L. J. (1988). Identification and characterization of the human lactoferrin-binding protein from Neisseria meningitidis. Infection and Immunity 56, 1144-1149.
52. Smith, D. S. (1996). Microbial pathogen genomes-new strategies for identifying therapeutics and vaccine targets. Trends in Biotechnology 14, 290-293.
53. Smith, D. R., Richterich, P., Rubenfield, M. & 34 other authors (1997). Multiplex sequencing of 1.5 Mb of the Mycobacterium leprae genome. Genome Research 7, 802-819.
54. Sodoyer, R., Mazarin, V., Guy, B.& 17 other authors (1998). Post-genomic strategies for vaccine target identification against Helicobacter pylori. In Abstracts of the 98th General Meeting of the American Society for Microbiology. Abstract E6.Washington D.C.: American Society for Microbiology.
55. Tomb, J. F., White, O., Kerlavage, A. R. and 39 other authors (1997). The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388, 539-547.
56. Wang, R., Doolan, D. L., Le, T. P.& 12 other authors (1998). Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476-480.
57. Webb, D.C.& Cripps, A.W. (1999). Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung. Infection and Immunity 67, 2138-2144.
58. Wild, J., Gruner, B., Metzqer, K., Kuhrober, A., Pudollek, H. P., Hauser, H., Schirmbeck, R.& Reimann, J. (1998). Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid. Vaccine 16, 353-360.
59. Wilkins, M. R., Sanchez, J. C., Williams, K. L.& Hochstrasser, D. F. (1996). Current challenges and future applications for protein maps and post-translational vector maps in proteome projects. Electrophoresis 17, 830-838.